Zusamenfassung
Im Rahmen des Tumorstagings wird bei 6–10% der Patientinnen mit Mammakarzinom bereits eine Fernmetastasierung detektiert (Harris et al. 1993). Metastasierungsorte für das Mammakarzinom sind in 15–20% die Lunge und Pleura (Pataphan et al. 1988). Etwa 20% aller Tumorrezidive manifestieren sich an der ventralen Brustwand oder im Sternum (Crowe et al. 1991). Die Resektion von Lungen-, Brustwand- und Sternummetastasen sind heute ein standardisiertes Therapiekonzept an spezialisierten thoraxchirurgischen Zentren. In der Regel sind die Metastasen mit einer niedrigen Morbidität und Letalität technisch gut resezierbar. Allerdings sind lediglich 30% der Patienten mit einer Lungenmetastasierung für eine Resektionsbehandlung geeignet. Selektionskriterien für dieses Therapiekonzept lassen sich nur in einer engen interdisziplinären Zusammenarbeit zwischen Thoraxchirurgen, gynäkologischen Onkologen und Strahlentherapeuten entwickeln. Das Hauptproblem der Metastasenchirurgie besteht darin, dass mit lokalen chirurgischen Maßnahmen eine generalisierte Erkrankung therapiert werden soll.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, Kabbaj O, Spano JP, Marsiglia H, Rouzier R, Delaloge S, Spielmann M (2004) Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 22: 3302–3308
Branscheid D, Krysa S, Wollkopf G, Bulzebruck H, Probst G, Horn M, Schirren J, Vogt-Moykopf I (1992) Does ND-YAG laser extend the indications for resection of pulmonary metastases? Eur J Cardiothorac Surg 6: 590
Cahan WG, Shah JP, Castro EB (1978) Benign solitary lung lesions in patients with cancer. Ann Surg 187: 241–244
Cerfolio RJ, McCartyT, Bryant AS (2009) Non-imaged pulmonary nodules discovered during thoracotomy for metastasectomy by lung palpation. Eur J Cardiothorac Surg 35: 786–791
Crowe JP Jr, Gordon NH, Antunez AR, Shenk RR, Hubay CA, Shuck JM, and Participating Investigators (1991) Local-regional breast cancer recurrence following mastectomy. Arch Surg 126: 429–32
Downey RJ, Rusch VW, Hsu FI, Leon L, Venkatraman E, Linehan D, Bains M, van Zee K, Korst R, Ginsberg RJ (2000) Chest wall resection for locally recurrent breast cancer: is it worthwhile? J Thorac Cardiovasc Surg 119: 420
Giordano SH, Buzdar AU, Kau SC, Hortobagyi GN (2002) Improvement in breast cancer survival: results from M.D. Anderson Cancer Center protocols from 1975-2000. Proc Am Soc Clin Oncol 21: 54a
Friedel G, Pastorino U, Ginsberg RJ, Goldstraw P, Johnston M, Pass H, Putnam JB, Toomes H (2002) Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the international registry of lung metastases. Eur J Cardiothorac Surg 22: 335
Harris JR, Morrow M, Bonnadonna G (1993) Cancer of the breast. In: DeVitta VT Jr, Hellman S, Rosenberg SA (eds) Cancer. Principles and Practice in Oncology, 4th ed). Lippincott, Philadelphia, pp 1264–1332
Norton L (1991) Metastatic breast cancer: Length and quality of life. N Engl J Med 325: 1370–1371
Pastorino U, Veronesi G, Landoni C, et al. (2003) Fazio FDG-PET improves preoperative staging of resectable lung metastasis. J Thorac Cardiovasc Surg 126: 1906–1910
Patanaphan V, Salazar OM, Risco R (1988) Breast cancer: metastatic patterns and their prognosis. South Med J 81: 1109–1112
Remy-Jardin M, Remy J, Giraud F, Marquette CH (1993) Pulmonary nodules: detection with thick-section spiral CT versus conventional CT. Radiology 187: 513
Rosen EL, Eubank WB, Mankoff DA (2007) FDG PET, PET/CT, and breast cancer imaging. RadioGraphics 27: S215–S229
Schirren J, Muley T, Schneider P et al. (1998) Chirurgische Therapie der Lungenmetastasen. In: Drings P, Vogt-Moykopf I (Hrsg) Thoraxtumoren. Springer, Berlin Heidelberg New York, pp 640–669
Schirren J, Muley T, Trainer S, Trainer C, Rick O, Vogt-Moykopf I (2006) Chirurgische Therapie von Lungenmetastasen. In: Schmoll, Höffken, Possinger (Hrsg) Kompendium Internistische Onkologie. Springer, Berlin Heidelberg New York, pp 958–993
Schirren J, Wassenberg D, Krysa S, Branscheid D, di Rienzo G, Drings P, Vogt-Moykopf I (1994) Surgery of lung metastasis — indications, results and prognostic factors as an interdisciplinary concept. Pneumologie 48(7): 469–74
Tanaka F, Li M, Hanaoka N, Bando T, Fukuse T, Hasegawa S, Wada H (2005) Surgery for Pulmonary Nodules in Breast Cancer Patients. Ann Thorac Surg 79: 1711–1714
Welter S, Jacobs J, Krbek T, Tötsch M, Stamatis G (2008) Pulmonary metastases of breast cancer. When is resection indicated? Eur J Cardiothorac Surg 34: 1228–1234
Vogt-Moykopf I, Krysa S, Bulzebruck H, Schirren J (1994) Surgery for pulmonary metastases. The Heidelberg experience. Chest Surg Clin N Am 4(1): 85–112
Literatur
Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giachetti S, Delvart V, Azoulay D, Bismuth H, Catsaing D (2006) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244(6): 897–907
Atalay G, Biganzoli L, Renard F, Paridaens R, Cufer T, Coleman R, Calvert AH, Gamucci T, Minisini A, Therasse P, Piccart MJ (2003) Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. Eur J Cancer 39(17): 2439–2449
Beadle G, Francis G, Stein S, Pandeya N, Purdie D (2004) Correlation of standard histological features and biomarkers with overall survival in breast cancer. Proc Am Soc Clin Oncol 23: 876
Braga L, Semelka R-C, Pietrobon R, Martin D, De-Barros N, Guller U (2004) Does hypervascularity of liver metastases as detected on MRI predict disease progression in breast cancer patients? Am J Roentgenol 182(5): 1207–1213
Caralt M, Bilbao I, Cortés J, Escartín A, Lázaro JL, Dopazo C, Olsina JJ, Balsells J, Charco R (2008) Hepatic resection for liver resection as part of the »oncosurgical« treatment of metastatic breast cancer. Ann Surg Oncol 15(10): 2804–10
D’Angelica M, Fong Y (2004) The Liver. In: Townsend C, Beauchamp R, Evers B, Mattox K (eds) Sabiston textbook of surgery — The biological basis of modern surgical practice. Elsevier Saunders, Philadelphia, pp 1513–1573
Diamond JR, Finlayson CA, Borges VF (2009) Hepatic complications of breast cancer. Lancet Oncol 10(6): 615–21
Eder M, Weiss M (1991) Hämatoge Lebermetastasen — humanpathologische Grundlagen. Chirurg 62: 705–709
Elias D, Di Pietroantonio D (2006) Surgery for liver metastases from breast cancer. HPB (Oxford) 8(2): 97–9
Fennessy FM, Mortele KJ, Kluckert T, Gogate A, Ondategui-Parra S, Ros P, Silverman SG (2004) Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis. Am J Roentgenol 18(3): 651–655
Friedrich M, Diesing D, Schroer A (2004) Hepatic metastasectomy as a cytoreductive strategy for the treatment of liver metastases in breast cancer: review of literature. Eur J Gynaecol Oncol 25(5): 555–558
Grassetto G, Fornasiero A, Bonciarelli G, Banti E, Rampin L, Marzola MC, Massaro A, Galeotti F, Del Favero G, Pasini F, Minicozzi AM, Al-Nahhas A, Cordiano C, Rubello D (2009) Additional value of FDG-PET/CT in management of »solitary« liver metastases: preliminary results of a prospective multicenter study. Mol Imaging Biol Jul 22 (Epub ahead of print)
Lamade W, Herfarth C (2001) Chirurgische Therapie von Lebermetastasen. In: Siewert J, Harder F, Rothmund M (Hrsg) Praxis der Viszeralchirurgie. Chirurgische Onkologie. Springer, Berlin Heidelberg New York, S 567
Lang H (2007) Liver resection: part II. Operative procedure. Chirurg 78(9): 849–63
Leonard G, Fong Y, Jarnagin W, Harris L, Schwartz L, D’angelica M, Paty P, Dematteo R, Blumgart LH, Kemeny N (2004) Liver resection after hepatic arterial infusion (HAI) plus sytemic oxaliplatin combinations in pretreated patients with extensive unresectable colorectal liver metastases. Proc Am Soc Clin Oncol 23: 256 (A)
Lermite E, Marzano E, Chéreau E, Rouzier R, Pesseaux P (2009) Surgial resection of liver metastases from breast cancer. Surg Oncol Jul 8 (Epub ahead of print)
Link KH, Pillasch J, Formentini A, Sunelaitis E, Leder G, Safi F, Kornmann M, Beger HG (1999) Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases. Eur J Surg Oncol 25(4): 381–388
Link KH, Sunelaitis E, Kornmann M, Schatz M, Gansauge F, Leder G, Formentini A, Staib L, Pillasch J, Beger H (2001) Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival. Cancer 92: 2746–2753
Liu MT, Huang WT, Wang AY, Huang CC, Huang CY, Chang TH, Pi CP, Yang HH (2009) Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index. Support Care Cancer Nov 11 (Epub ahead of print)
Lubrano J, Roman H, Tarrab S, Resch B, Marpeau L, Scotté M (2008) Liver resection for breast cancer metastasis: does it improve survival? Surg Today 38(4): 293–9
Meloni MF, Andreano A, Laeseke PF, Livraghi T, Sironi S, Lee FT Jr. (2009) Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation — intermediate and long-term survival rates. Radiology 253(3): 861–9
Paviot BT, Bachelot T, Clavreul G, Jacquin JP, Mille D, Rodrigues JM (2009) Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and survival time of 371 patients treated in three hospitals of Rhone-Alpes region. Bull Cancer 96(10): 929–40
Pentheroudakis G, Fountzilas G, Bafaloukos D, Koutsoukou V, Pectasides D, Skarlos D, Samantas E, Kalofonos HP, Gogas H, Pavlidis N (2006) Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Breast Cancer Res Treat 97(3): 237–44
Perrone M, Musolino A, Michiara M, Di Blasio B, Bella M, Franciosi V, Cocconi G, Camisa R, Todeschini R, Cascinu S (2004) Early detection of recurrences in the follow-up of primary breast cancer in an asymptomatic or symptomatic phase. Tumori 90(3): 276–279
Raab R, Nussbaum K, Werner U, Pichlmayr R (1996) Lebermetastasen bei Mammacarcinom — Ergebnisse der Leberteilresektion. Chirurg 67(3): 234–237
Rubin D, Nutting C, Jones B (2004) Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization. Integr Cancer Ther 3(3): 262–267
Schneider C, Fehr M, Steiner R, Hagen D, Haller U, Fink D (2004) Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation. Arch Gynecol Obstet 269(1): 9–12
Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien PA (2000) Liver metastases from breast cancer: long-term survival after curative resection. Surgery 127(4): 383–9
Vlastos G, Smith D, Singletary S, Mirza N, Tuttle T, Popat R, Curley S, Ellis L, Roh M, Vauthey J (2004) Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 11(9): 869–874
Wilson JM, Carder P, Downey S, Davies MH, Wyatt JI, Brennan TG (2003) Treatment of metastatic breast cancer with liver transplantation. Breast J 9(2): 126–128
Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Cheung KL, Robertson JF, Evans AJ (2003) Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 89(2): 284–290
Literatur
Chow E, Holden L, Danjoux C, Yee A, Vidmar M, Connolly R, Finkelstein J, Chung G (2004) Successful salvage using percutaneous vertebroplasty in cancer patients with painful spinal metastases or osteoporotic compression fractures. Radiother Oncol 70: 265–267
Coleman RE (1997) Skeletal complications of malignancy. Cancer 80 (Suppl 8): 1588–1594
Flickinger FW, Sanal SM (1994) Bone marrow MRI: techniques and accuracy for detecting breast cancer metastases. Magn Reson Imaging 12: 829–835
Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT (2004) Bone imaging in metastatic breast cancer. J Clin Oncol 22: 2942–2953
Harrington KD (1997) Orthopedic surgical management of skeletal complications of malignancy. Cancer 80: 1614–1627
Krempien B (1995) Zur Pathogenese von Knochenmetastasen und Tumorosteopathien. Radiologe 35: 1–7
Michaelson MD, Smith MR (2005) Bisphosphonates for treatment and prevention of bone metastases. J Clin Oncol 23: 8219–8224
Mirels H (1989) Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 249: 256–264
Ohta M, Tokuda Y, Suzuki Y, Kubota M, Makuuchi H, Tajima T, Nasu S, Suzuki Y, Yasuda S, Shohtsu A (2001) Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun 22: 875–879
Rieden K (1988) Knochenmetastasen. Radiologische Diagnostik, Therapie und Nachsorge. Springer, Berlin Heidelberg New York Tokio
Schirrmeister H, Guhlmann A, Kotzerke J et al. (1999) Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 17: 2381–2389
Sundaresan N, Steinberger AA, Moore F, Sachdev VP, Krol G, Hough L, Kelliher K (1996) Indications and results of combined anteriorposterior approaches for spine tumor surgery. J Neurosurg 85: 438–446
Townsend PW, Smalley SR, Cozad SC, Rosenthal HG, Hassanein RE (1995) Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. Int J Radiat Oncol Biol Phys 31: 43–49
Van der Linden Y, Dijkstra PD, Kroon HM, Lok JJ, Noordijk EM, Leer JW, Marijnen CAM (2004) Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br 86: 566–573
Windhager R, Ritschl P, Rokus U, Kickinger W, Braun O, Kotz R (1989) Die Rezidivhäufigkeit von intra-und extraläsional operierten Metastasen langer Röhrenknochen. Z Orthop 127: 402–405
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg New York
About this chapter
Cite this chapter
Schirren, J., Orend, KH., Bölükbas, S., Staib, L., Schulte, M. (2010). Operative Therapie bei Metastasen. In: Mammakarzinom Interdisziplinär. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12681-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-12681-9_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12680-2
Online ISBN: 978-3-642-12681-9
eBook Packages: Medicine (German Language)